Two Additional Board Appointments Expected in 2024 as NuView Advances Pipeline of Theranostic Radiopharmaceuticals for Various Cancers PARK CITY, Utah, Jan. 3, 2024 /PRNewswire/ — NuView Life Sciences, Inc. (“NuView”, the “company”), a radiopharmaceutical company seeking to enhance the…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.